Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print July 2, 2008, 10.1097/PSY.0b013e31816ffc39
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mattila, A. K.
Right arrow Articles by Joukamaa, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mattila, A. K.
Right arrow Articles by Joukamaa, M.
Psychosomatic Medicine 70:716-722 (2008)
© 2008 American Psychosomatic Society


ORIGINAL ARTICLES

Alexithymia and Somatization in General Population

Aino K. Mattila, MD, Erkki Kronholm, PhD, Antti Jula, MD, PhD, Jouko K. Salminen, MD, PhD, Anna-Maija Koivisto, MSc, Riitta-Liisa Mielonen, MD and Matti Joukamaa, MD, PhD

From the Tampere School of Public Health, University of Tampere (A.K.M., A.M.K., M.J.), Department of Psychiatry, Tampere University Hospital (A.K.M., M.J.), Tampere, Finland; National Public Health Institute, Department of Health and Functional Capacity, Laboratory for Population Research (E.K., A.J., J.K.S.), Adolescent Psychiatry Outpatient Clinic, Turku University Central Hospital (R.-L.M.), Turku, Finland; and National Public Health Institute, Helsinki, Finland (M.J.).

Address correspondence and reprint requests to Aino K. Mattila, Tampere School of Public Health, FIN-33014 University of Tampere, Tampere, Finland. E-mail: aino.mattila{at}uta.fi

Objective: Even though the association between alexithymia and somatization seems plausible according to several studies with selected populations, it has not been verified in carefully controlled and nationally representative population studies. We conducted such a study to find out whether alexithymia is associated with somatization at population level.

Methods: This study was a part of the Finnish Health 2000 Study. The nationally representative sample comprised 5129 subjects aged 30 to 97 years. Alexithymia was measured with the 20-item Toronto Alexithymia Scale (TAS-20) and somatic symptom reporting with the 12-item somatization scale derived from the Hopkins Symptom Checklist. Sociodemographic and health-related variables, including depressive and anxiety disorders, and physician verified somatic diagnoses, were treated as confounders in multivariate analyses.

Results: Alexithymia was associated with somatization independently of somatic diseases, depression and anxiety and confounding sociodemographic variables. The TAS-20 factor scale "Difficulties Identifying Feelings" was the strongest common denominator between alexithymia and somatization.

Conclusions: This was the first time the independent association between alexithymia and somatization was established in a large, nationally representative nonclinical sample of both young and old adults with and without mental disorders and somatic diseases.

Key Words: alexithymia • general population • somatization

Abbreviations: TAS-20 = 20-item version of the Toronto Alexithymia Scale; DIF = difficulties identifying feelings; DDF = difficulties describing feelings; EOT = externally orientated thinking; SCL-90 = Hopkins Symptom Checklist; SCL SOM = 12-item somatization scale derived from SCL-90; M-CIDI = Munich version of the Composite International Diagnostic Interview; ICD-10 = International Statistical Classification of Diseases and Related Health Problems, 10th Revision; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; SEM = structural equation modeling.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Psychosomatic Society